| Date Filed | Type | Description |
| 02/28/2023 |
4
| Lutz Robert Matthew (COO) has filed a Form 4 on Savara Inc|
Txns:
| Granted 140,000 shares
@ $0
Granted 350,000 options to buy
@ $2.53, valued at
$885.5k
|
|
| 02/22/2023 |
3
| Lutz Robert Matthew (COO) has filed a Form 3 on Savara Inc |
| 11/15/2022 |
4
| Lutz Robert Matthew (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 100,057 shares
@ $0 |
|
| 08/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Lutz Robert Matthew (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 232,000 shares
@ $0
Granted 350,000 options to buy
@ $1.43, valued at
$500.5k
|
|
| 03/04/2021 |
3
| Lutz Robert Matthew (See Remarks) has filed a Form 3 on iBio, Inc. |
| 02/23/2021 |
4
| Lutz Robert Matthew (CFO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 6,978 shares
@ $3.62, valued at
$25.3k
|
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2020 |
4
| Lutz Robert Matthew (CFO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 275,000 options to buy
@ $2.98, valued at
$819.5k
|
|
| 09/04/2019 |
3
| Lutz Robert Matthew (CFO) has filed a Form 3 on Strongbridge Biopharma plc |